These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23190708)

  • 41. Scleroderma and IgG4-related disease.
    Reddi DM; Cardona DM; Burchette JL; Puri PK
    Am J Dermatopathol; 2013 Jun; 35(4):458-62. PubMed ID: 23563250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort.
    Iudici M; Codullo V; Giuggioli D; Riccieri V; Cuomo G; Breda S; Manfredi A; Iannace N; D'Alto M; Ghio S; Rossi R; Vizza CD; Caporali R; Valesini G; Ferri C; Valentini G
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):31-6. PubMed ID: 23910607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autonomic dysfunction in diffuse scleroderma vs CREST: an assessment by computerized heart rate variability.
    Hermosillo AG; Ortiz R; Dábague J; Casanova JM; Martínez-Lavín M
    J Rheumatol; 1994 Oct; 21(10):1849-54. PubMed ID: 7837149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Incidence, prevalence and disease characteristics of systemic sclerosis in Split-Dalmatia County].
    Kaliterna DM; Radić M; Pavić A
    Reumatizam; 2010; 57(2):94-8. PubMed ID: 21875011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings.
    Venturini M; Arisi M; Zanca A; Cavazzana I; Gonzàlez S; Franceschini F; Calzavara-Pinton P
    Eur J Dermatol; 2014; 24(3):349-55. PubMed ID: 24721824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of systemic sclerosis.
    Medsger TA
    Clin Dermatol; 1994; 12(2):207-16. PubMed ID: 8076257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients.
    Maricq HR; Valter I
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S5-13. PubMed ID: 15344590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.
    Roberts-Thomson PJ; Walker JG; Lu TY; Esterman A; Hakendorf P; Smith MD; Ahern MJ
    Intern Med J; 2006 Aug; 36(8):489-97. PubMed ID: 16866652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney disease other than renal crisis in patients with diffuse scleroderma.
    Steen VD; Syzd A; Johnson JP; Greenberg A; Medsger TA
    J Rheumatol; 2005 Apr; 32(4):649-55. PubMed ID: 15801020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the burden of scleroderma disease in Spain.
    Villaverde-Hueso A; Sánchez-Valle E; Alvarez E; Morant C; Carreira PE; Martín-Arribas MC; Gènova R; Ramírez-González A; de la Paz MP
    J Rheumatol; 2007 Nov; 34(11):2236-42. PubMed ID: 17918783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study.
    Tseng CC; Yen JH; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Chang SJ
    BMC Musculoskelet Disord; 2015 Sep; 16():251. PubMed ID: 26370572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.
    Thompson AE; Pope JE
    J Rheumatol; 2002 Sep; 29(9):1867-73. PubMed ID: 12233880
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
    Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of the ICD-9-CM code for systemic sclerosis using updated ACR/EULAR classification criteria.
    Valenzuela A; Yaqub A; Fiorentino D; Krishnan E; Chung L
    Scand J Rheumatol; 2015 May; 44(3):253-5. PubMed ID: 25744697
    [No Abstract]   [Full Text] [Related]  

  • 56. Scleroderma in South Australia: epidemiological observations of possible pathogenic significance.
    Roberts-Thomson PJ; Jones M; Hakendorf P; Kencana Dharmapatni AA; Walker JG; MacFarlane JG; Smith MD; Ahern MJ
    Intern Med J; 2001; 31(4):220-9. PubMed ID: 11456035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on scleroderma.
    Williamson DJ
    Med J Aust; 1995 Jun; 162(11):599-601. PubMed ID: 7791647
    [No Abstract]   [Full Text] [Related]  

  • 58. An epidemiological study of scleroderma in the West Midlands.
    Silman A; Jannini S; Symmons D; Bacon P
    Br J Rheumatol; 1988 Aug; 27(4):286-90. PubMed ID: 3261609
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignancy in scleroderma patients from south west England: a population-based cohort study.
    Siau K; Laversuch CJ; Creamer P; O'Rourke KP
    Rheumatol Int; 2011 May; 31(5):641-5. PubMed ID: 20058012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Auto-immune disorders in localized scleroderma.
    Rondinone R; Germino M; Sartori E; Veller Fornasa C; Ruffatti A; Betterle C; Peserico A
    Arch Dermatol Res; 1990; 282(7):477-9. PubMed ID: 2078051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.